The Recall Desk

FDA (Drugs) recall action 73101

Perrigo Company PLC recalled 2 products on 2016-02-10

The FDA (Drugs) publishes a recall like this one as 2 separate product records. They share a firm, a date and a cause; this page is all of them in one place, so the scale of the action is visible rather than spread across 2 pages.

Products
2
Announced
2016-02-10
Critical
0
Units
1,866

Why these products were recalled

Labeling: label error on declared strength.

The agency’s own wording, quoted from the enforcement report.

The unit total adds up the quantities the agency stated for each product. Where a product record gave no figure, or gave a weight rather than a count, it contributes nothing — so the real total is at least this, never less.

1–2 of 2

  • ModerateFDA (Drugs)··2016-02-10

    Perrigo Recalls Nystatin Powder for Labeling Error on Declared Strength

    Perrigo is recalling 918 units of Nystatin USP Powder due to a labeling error regarding the declared strength. The product was distributed nationwide.

    Product
    Nystatin, USP Powder for Rx compounding, 150 Million Units, Packaged by Perrigo, Minneapolis MN 55427, NDC 0574-0404-15, UPC 305740404157
    Category
    Distribution
    0 states
  • ModerateFDA (Drugs)··2016-02-10

    Perrigo Recalls Nystatin Powder for Labeling Error on Declared Strength

    Perrigo Company PLC is recalling Nystatin, USP Powder for Rx compounding due to a labeling error regarding the declared strength.

    Product
    Nystatin, USP Powder for Rx compounding, 50 Million Units, Packaged by Perrigo, Minneapolis MN 55427, NDC 0574-0405-05, UPC 305740404058.
    Category
    Distribution
    0 states